H.R. 9559 aims to speed up the research, development, and accessibility of psychedelic drugs that have the potential to treat serious mental illnesses in the U.S. The bill seeks to address the growing crisis of mental health issues by facilitating the use of these substances in therapeutic settings.
Supporters of H.R. 9559 highlight the bill as a groundbreaking step forward in mental health treatment, emphasizing the potential life-saving benefits of psychedelic therapies. Advocates argue that this legislation could lead to innovative solutions for conditions like depression, PTSD, and anxiety, which affect millions of Americans.
Critics of H.R. 9559 express concerns about the safety and regulation of psychedelic drugs, warning that hastening their development and access could lead to misuse and unintended consequences. Some argue that the bill may undermine existing mental health treatment protocols and that more research is needed before such substances are widely available.
The bill H.R. 9559 aims to accelerate the development and access to psychedelic drugs for treating serious mental illness. The primary sponsor, Morgan Luttrell, has received substantial donations from the Health Professionals industry, totaling $120 million. This significant financial backing raises concerns about potential conflicts of interest, as the bill directly pertains to health-related issues, particularly mental health treatments. The overwhelming majority of Luttrell's donations come from individuals within this sector, suggesting a strong alignment between his financial supporters and the legislative agenda of the bill.
Additionally, the lobbying activity in this policy area includes various organizations, such as the Committee to Protect Health Care, which has undisclosed contributions, and Blue Cross and Blue Shield of Kansas, which contributed $10,000. The presence of these lobbying entities alongside Luttrell's donor base indicates a potential for undue influence on the legislative process, particularly if the interests of these donors are prioritized over public health needs. Voters should be aware of these connections, as they may affect the integrity of the bill's intentions and its outcomes for mental health treatment accessibility.
These industries are both affected by this bill and among the sponsor's top donors.
| Industry | Match Type | Related Subject | Donations |
|---|---|---|---|
| Health Professionals (H01) | Sector | Health | $120,000,000 |
| Total from overlapping industries | $120,000,000 | ||
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| AMERICAN ISRAEL PUBLIC AFFAIRS COMMITTEE | AMERICAN ISRAEL PUBLIC AFFAIRS COMMITTEE | $810,990 |
| AMERICAN LEGION | THE AMERICAN LEGION | $190,000 |
| ACADEMY OF MODEL AERONAUTICS | CAPITOL HILL POLICY GROUP LLC | $50,000 |
| CALISTA CORPORATION | CAPITOL HILL POLICY GROUP LLC | $50,000 |
| PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION | PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION | $50,000 |
| NATIONAL EDUCATION ASSOCIATION | ROCK CREEK COUNSEL | $40,000 |
| PUGET SOUND ENERGY | ROCK CREEK COUNSEL | $30,000 |
| KOOTENAI TRIBE OF IDAHO | CAPITOL HILL POLICY GROUP LLC | $20,000 |
| MICRON TECHNOLOGIES, INC. | OFF HILL STRATEGIES L.L.C. | $20,000 |
| BLUE CROSS AND BLUE SHIELD OF KANSAS INC | BLUE CROSS AND BLUE SHIELD OF KANSAS, INC. | $10,000 |
| EXODIGO, LLC (ON BEHALF OF GROISMAN, LLC) | EJK, LLC | $10,000 |
| TERAMIND, INC. (ON BEHALF OF GROISMAN, LLC) | EJK, LLC | $5,000 |
| COMMITTEE TO PROTECT HEALTH CARE | COMMITTEE TO PROTECT HEALTH CARE | undisclosed |
| INTELSAT GENERAL CORPORATION | VELOS | undisclosed |
| JETBLUE AIRWAYS CORPORATION | ECKERT SEAMANS CHERIN & MELLOTT, LLC | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Morgan Luttrell, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
